Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
P 1 (1)

Trial Status

Enrolling By Invitation1
Recruiting1
Terminated1
Withdrawn1
Active Not Recruiting1

Clinical Trials (5)

Showing 5 of 5 trials
NCT07219680Not ApplicableRecruiting

Intervention for Communication Quality of Life in Primary Progressive Aphasia

NCT04881617Not ApplicableActive Not Recruiting

Treatment for Speech and Language in Primary Progressive Aphasia

NCT06649084Not ApplicableEnrolling By Invitation

Primary Progressive Aphasia Multicomponent Language Treatment Study

NCT04883229Not ApplicableWithdrawnPrimary

tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study

NCT03658135Phase 1Terminated

BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

Showing all 5 trials

Research Network

Activity Timeline